AIM-HI Accelerator Fund

What they do

Founded in 2019 by the National Foundation for Cancer Research (NFCR), AIM-HI Accelerator Fund is a 501(c)(3) non-profit impact investor. It focuses on bridging the "Valley of Death" for early-stage oncology and STEM companies by providing critical seed funding, coaching, and access to a global network of scientific and clinical leaders. The firm is distinctive for its venture philanthropy approach, employing an "Evergreen Model" where returns on successful investments are reinvested into new cancer discoveries in a self-perpetuating cycle. AIM-HI is highly regarded in the life sciences ecosystem for its specialized venture competitions, including the Women's Venture Competition and the BRACE Award, which specifically target underfunded demographics and underserved patient populations.

What they look for

AIM-HI's mission is to bridge the gap between research breakthroughs and clinical trials by funding early-stage oncology and STEM startups. They aim to accelerate the commercialization of innovative laboratory discoveries into new therapies and technologies that can save cancer patients' lives.

Stage

Pre-seed, Seed, Series A

Sectors

Healthcare, Deeptech

Based

Rockville, US